Cardlytics (NASDAQ:CDLX) CFO Alexis Desieno Sells 8,607 Shares

Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno sold 8,607 shares of Cardlytics stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $1.17, for a total transaction of $10,070.19. Following the sale, the chief financial officer owned 201,159 shares of the company’s stock, valued at $235,356.03. The trade was a 4.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Cardlytics Price Performance

Shares of CDLX stock opened at $1.24 on Tuesday. The company has a market capitalization of $67.03 million, a P/E ratio of -0.59, a P/E/G ratio of 0.18 and a beta of 1.05. The company’s 50-day simple moving average is $1.29 and its two-hundred day simple moving average is $1.59. Cardlytics, Inc. has a one year low of $0.85 and a one year high of $4.05. The company has a debt-to-equity ratio of 2.87, a current ratio of 1.14 and a quick ratio of 1.14.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.08. Cardlytics had a negative net margin of 44.12% and a negative return on equity of 235.70%. The firm had revenue of $52.03 million during the quarter, compared to the consensus estimate of $56.64 million. As a group, equities analysts anticipate that Cardlytics, Inc. will post -1.52 EPS for the current year.

Institutional Investors Weigh In On Cardlytics

Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Personalized Indexing Management LLC bought a new position in Cardlytics in the third quarter worth about $26,000. Catalyst Funds Management Pty Ltd bought a new stake in shares of Cardlytics in the 2nd quarter valued at about $32,000. Post Resch Tallon Group Inc. grew its position in shares of Cardlytics by 100.0% in the 2nd quarter. Post Resch Tallon Group Inc. now owns 20,000 shares of the company’s stock worth $33,000 after buying an additional 10,000 shares during the last quarter. Sand Hill Global Advisors LLC bought a new position in shares of Cardlytics during the 2nd quarter worth approximately $35,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Cardlytics during the 2nd quarter worth approximately $42,000. Institutional investors own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cardlytics in a research report on Monday, December 29th. Three investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Cardlytics has an average rating of “Reduce” and a consensus target price of $2.25.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.